BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 28923816)

  • 21. Design of a randomized controlled trial to assess the comparative effectiveness of a multifaceted intervention to improve three-year adherence to colorectal cancer screening among patients cared for in rural community health centers.
    Davis TC; Morris JD; Reed EH; Curtis LM; Wolf MS; Davis AB; Arnold CL
    Contemp Clin Trials; 2022 Feb; 113():106654. PubMed ID: 34906745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Equivalent Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening Program.
    Wieten E; de Klerk CM; van der Steen A; Ramakers CR; Kuipers EJ; Hansen BE; Lansdorp-Vogelaar I; Bossuyt PM; Dekker E; Spaander MCW
    Gastroenterology; 2018 Nov; 155(5):1392-1399.e5. PubMed ID: 30055170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Community-Based Colorectal Cancer Screening in a Rural Population: Who Returns Fecal Immunochemical Test (FIT) Kits?
    Crosby RA; Stradtman L; Collins T; Vanderpool R
    J Rural Health; 2017 Sep; 33(4):371-374. PubMed ID: 27650560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-year follow-up of the effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers.
    Baker DW; Brown T; Goldman SN; Liss DT; Kollar S; Balsley K; Lee JY; Buchanan DR
    Cancer Causes Control; 2015 Nov; 26(11):1685-90. PubMed ID: 26337733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal Cancer.
    Nielson CM; Vollmer WM; Petrik AF; Keast EM; Green BB; Coronado GD
    J Gen Intern Med; 2019 Jun; 34(6):978-985. PubMed ID: 30684199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'Simple and easy:' providers' and latinos' perceptions of the fecal immunochemical test (FIT) for colorectal cancer screening.
    Aguado Loi CX; Martinez Tyson D; Chavarria EA; Gutierrez L; Klasko L; Davis S; Lopez D; Johns T; Meade CD; Gwede CK
    Ethn Health; 2020 Feb; 25(2):206-221. PubMed ID: 29319331
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
    Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
    JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeat Annual Colorectal Cancer Screening in Rural Community Clinics: A Randomized Clinical Trial to Evaluate Outreach Strategies to Sustain Screening.
    Davis TC; Rademaker A; Morris J; Ferguson LA; Wiltz G; Arnold CL
    J Rural Health; 2020 Jun; 36(3):307-315. PubMed ID: 31523848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Effectiveness of Multifaceted Outreach to Initiate Colorectal Cancer Screening in Community Health Centers: A Randomized Controlled Trial.
    Goldman SN; Liss DT; Brown T; Lee JY; Buchanan DR; Balsley K; Cesan A; Weil J; Garrity BH; Baker DW
    J Gen Intern Med; 2015 Aug; 30(8):1178-84. PubMed ID: 25814264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Participant uptake of the fecal immunochemical test decreases with the two-sample regimen compared with one-sample FIT.
    Mosen DM; Liles EG; Feldstein AC; Perrin N; Rosales AG; Keast E; Smith DH
    Eur J Cancer Prev; 2014 Nov; 23(6):516-23. PubMed ID: 25203483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study.
    Jensen CD; Corley DA; Quinn VP; Doubeni CA; Zauber AG; Lee JK; Zhao WK; Marks AR; Schottinger JE; Ghai NR; Lee AT; Contreras R; Klabunde CN; Quesenberry CP; Levin TR; Mysliwiec PA
    Ann Intern Med; 2016 Apr; 164(7):456-63. PubMed ID: 26811150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of Colon Cancer Screening by Fecal Immunochemical Test in Iran.
    Salimzadeh H; Bishehsari F; Sauvaget C; Amani M; Hamzehloo G; Nikfarjam A; Merat S; Delavari A; Malekzadeh R
    Arch Iran Med; 2017 Dec; 20(12):726-733. PubMed ID: 29664311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing sampling device for the fecal immunochemical test increases colonoscopy yields in colorectal cancer screening.
    Huang Y; Li Q; Ge W; Hu Y; Cai S; Yuan Y; Zhang S; Zheng S
    Eur J Cancer Prev; 2016 Mar; 25(2):115-22. PubMed ID: 25768975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health Care Provider Characteristics Associated With Colorectal Cancer Screening Preferences and Use.
    Finney Rutten LJ; Parks PD; Weiser E; Fan C; Jacobson DJ; Jenkins GD; Zhu X; Griffin JM; Limburg PJ
    Mayo Clin Proc; 2022 Jan; 97(1):101-109. PubMed ID: 34920895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uptake of colorectal cancer screening after mailed fecal immunochemical test (FIT) outreach in a newly eligible 45-49-year-old community health center population.
    O'Leary MC; Reuland DS; Correa SY; Moore AA; Malo TL; Tan X; Rohweder CL; Wheeler SB; Brenner AT
    Cancer Causes Control; 2023 Dec; 34(Suppl 1):125-133. PubMed ID: 37300632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening.
    Gies A; Cuk K; Schrotz-King P; Brenner H
    Clin Transl Gastroenterol; 2018 Jul; 9(7):168. PubMed ID: 29976921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
    Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW
    Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening.
    Shapiro JA; Bobo JK; Church TR; Rex DK; Chovnick G; Thompson TD; Zauber AG; Lieberman D; Levin TR; Joseph DA; Nadel MR
    Am J Gastroenterol; 2017 Nov; 112(11):1728-1735. PubMed ID: 29016558
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.